Biomarker-Oriented Therapy in Bladder and Renal Cancer

Biomarker-Oriented Therapy in Bladder and Renal Cancer

Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards biomarker-directed therapy are being investigated. Immune checkpoint inhibition (ICI) or fibroblast growth factor receptor (FGFR) directed therapy are...

Full description

Bibliographic Details
Main Authors: Mathijs P. Scholtes, Arnout R. Alberts, Iris G. Iflé, Paul C. M. S. Verhagen, Astrid A. M. van der Veldt, Tahlita C. M. Zuiverloon
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
biomarker guided therapy
targeted therapy
bladder cancer
renal cancer
immune checkpoint inhibitor
Online Access:https://www.mdpi.com/1422-0067/22/6/2832

Similar Items

Similar Items